We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
淋巴细胞活化基因 3 在肝脏相关疾病中的研究进展.
- Authors
陈锐; 王志鑫; 樊海宁; 王海久
- Abstract
Immune checkpoint inhibitors ( IC Is) therapy has shown broad prospects in the treatment of malignant tumors and infectious diseases, but problems encountered during application drive researchers to explore potential immune checkpoints. This article summarizes the research advances in the role of the new immune checkpoint lymphocyte activation gene - 3 ( LAG - 3) in liver - related diseases, aiming to provide a reference for subsequent research. LAG - 3 is expected to become the classic target of next - generation ICis therapy and play a key role in immunotherapy for liver - related diseases.
- Publication
Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2021, Vol 37, Issue 4, p977
- ISSN
1001-5256
- Publication type
Article
- DOI
10.3969/j.issn.1001-5256.2021.04.056